Muriel Meiring

906 total citations
40 papers, 735 citations indexed

About

Muriel Meiring is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Muriel Meiring has authored 40 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 13 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Muriel Meiring's work include Platelet Disorders and Treatments (28 papers), Blood groups and transfusion (15 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (10 papers). Muriel Meiring is often cited by papers focused on Platelet Disorders and Treatments (28 papers), Blood groups and transfusion (15 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (10 papers). Muriel Meiring collaborates with scholars based in South Africa, Belgium and Australia. Muriel Meiring's co-authors include Hans Deckmyn, Nancy Cauwenberghs, Harry F. Kotzé, Emmanuel J. Favaloro, Jan Roodt, Seb Lamprecht, Karen Vanhoorelbeke, Roslyn Bonar, Dong‐Mei Wu and Hilde Depraetere and has published in prestigious journals such as Blood, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Muriel Meiring

39 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muriel Meiring South Africa 15 534 216 171 97 96 40 735
Hironobu Anbo Japan 5 474 0.9× 179 0.8× 139 0.8× 63 0.6× 66 0.7× 7 610
Paulette Legendre France 19 605 1.1× 96 0.4× 121 0.7× 350 3.6× 45 0.5× 30 873
M. Bérard France 15 225 0.4× 77 0.4× 87 0.5× 82 0.8× 29 0.3× 34 586
Sonja Werwitzke Germany 13 471 0.9× 36 0.2× 202 1.2× 171 1.8× 39 0.4× 38 752
Ingrid Hrachovinová Czechia 11 406 0.8× 168 0.8× 150 0.9× 296 3.1× 133 1.4× 36 868
Paul E. R. Ellery United States 11 342 0.6× 70 0.3× 47 0.3× 41 0.4× 62 0.6× 18 498
Zohra Ahmadi Australia 8 222 0.4× 38 0.2× 183 1.1× 272 2.8× 63 0.7× 17 588
Maurits L. van Montfoort Netherlands 10 133 0.2× 46 0.2× 77 0.5× 183 1.9× 78 0.8× 24 439
Shawn Tinlin Canada 15 655 1.2× 76 0.4× 103 0.6× 82 0.8× 48 0.5× 18 953

Countries citing papers authored by Muriel Meiring

Since Specialization
Citations

This map shows the geographic impact of Muriel Meiring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Meiring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Meiring more than expected).

Fields of papers citing papers by Muriel Meiring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Meiring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Meiring. The network helps show where Muriel Meiring may publish in the future.

Co-authorship network of co-authors of Muriel Meiring

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Meiring. A scholar is included among the top collaborators of Muriel Meiring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Meiring. Muriel Meiring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Meiring, Muriel, et al.. (2021). The effects of streptokinase in a Chacma baboon (Papio ursinus) model of acquired thrombotic thrombocytopenic purpura. Clinical and Experimental Medicine. 21(4). 663–674. 2 indexed citations
3.
Schapkaitz, Elise, Elena Libhaber, Barry Jacobson, Muriel Meiring, & Harry R. Büller. (2021). von Willebrand factor propeptide‐to‐antigen ratio in HIV‐infected pregnancy: Evidence of endothelial activation. Journal of Thrombosis and Haemostasis. 19(12). 3168–3176. 2 indexed citations
4.
Meiring, Muriel, et al.. (2020). Verification of a rapid von Willebrand factor propeptide assay. 78–82. 1 indexed citations
5.
6.
Vermeulen, Jan‐G, Felicity J. Burt, Esta van Heerden, Errol D. Cason, & Muriel Meiring. (2018). Evaluation of in vitro refolding vs cold shock expression: Production of a low yielding single chain variable fragment. Protein Expression and Purification. 151. 62–71. 8 indexed citations
7.
Favaloro, Emmanuel J., Roslyn Bonar, Martine J. Hollestelle, et al.. (2018). Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: A large international cross-laboratory study. Thrombosis Research. 166. 96–105. 22 indexed citations
8.
Meiring, Muriel, et al.. (2016). Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells. International Journal of Medical Sciences. 13(10). 759–764. 7 indexed citations
9.
Favaloro, Emmanuel J., Muriel Meiring, Elizabeth M. Duncan, et al.. (2014). Evaluating errors in the laboratory identification of von Willebrand disease in the real world. Thrombosis Research. 134(2). 393–403. 51 indexed citations
10.
Malan, Nicolaas T., Roland von Känel, Aletta E. Schutte, et al.. (2013). Testosterone and acute stress are associated with fibrinogen and von Willebrand factor in African men: The SABPA study. International Journal of Cardiology. 168(5). 4638–4642. 11 indexed citations
11.
Favaloro, Emmanuel J., Roslyn Bonar, Kent Chapman, Muriel Meiring, & Dorothy M. Funk. (2012). Differential sensitivity of von Willebrand factor (VWF) ‘activity’ assays to large and small VWF molecular weight forms: a cross‐laboratory study comparing ristocetin cofactor, collagen‐binding and mAb‐based assays. Journal of Thrombosis and Haemostasis. 10(6). 1043–1054. 44 indexed citations
12.
Rensburg, Walter J. Janse van, Jan Roodt, Seb Lamprecht, Muriel Meiring, & P N Badenhorst. (2012). Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates. Clinical and Experimental Medicine. 12(4). 257–263. 4 indexed citations
13.
Meiring, Muriel, et al.. (2011). Laboratory Diagnosis and Management ofvon Willebrand Disease in South Africa. Seminars in Thrombosis and Hemostasis. 37(5). 576–580. 8 indexed citations
14.
Meiring, Muriel, et al.. (2009). Laboratory Diagnosis of von Willebrand Disease. European Oncology & Haematology. 3(1). 33–33. 2 indexed citations
15.
Favaloro, Emmanuel J., Jim Thom, Sarah Just, et al.. (2009). Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease. Blood Coagulation & Fibrinolysis. 20(6). 475–483. 20 indexed citations
16.
Jacquemin, Marc, J M Stassen, Peter Verhamme, et al.. (2008). A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons. Journal of Thrombosis and Haemostasis. 7(3). 429–437. 17 indexed citations
17.
Meiring, Muriel, et al.. (2007). Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease. Clinical Chemistry and Laboratory Medicine (CCLM). 45(8). 1068–72. 12 indexed citations
18.
Meiring, Muriel, et al.. (2005). A rapid and cost-effective method to visualize von Willebrand factor multimers in plasma. 19(2). 16–18. 1 indexed citations
19.
Viaene, Angela N., et al.. (2001). Identification of a Collagen-Binding Protein fromNecator americanusby Using acDNA-Expression Phage Display Library. Journal of Parasitology. 87(3). 619–625. 10 indexed citations
20.
Meiring, Muriel, M. G. Lötter, P N Badenhorst, et al.. (1999). Sites of elimination and pharmacokinetics of recombinant [131I]lepirudin in baboons. Journal of Pharmaceutical Sciences. 88(5). 523–529. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hironobu Anbo Breakdown of academic impact, for papers by Paulette Legendre Breakdown of academic impact, for papers by M. Bérard Breakdown of academic impact, for papers by Sonja Werwitzke Breakdown of academic impact, for papers by Ingrid Hrachovinová Breakdown of academic impact, for papers by Paul E. R. Ellery Breakdown of academic impact, for papers by Zohra Ahmadi Breakdown of academic impact, for papers by Maurits L. van Montfoort Breakdown of academic impact, for papers by Shawn Tinlin
Rankless by CCL
2026